Evidence method
Sequential · gp.financial.deposits
-3.26% · CORE · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CIVB · Dec 31, 2022
CIVISTA BANCSHARES, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000950170-23-011581Bank
Evidence method
Yoy · gp.fundamentals.net_income
-2.76% · CORE · VALID
Evidence method
Yoy · gp.financial.interest_expense
74.91% · CORE · VALID
Evidence method
Yoy · gp.financial.interest_income
19.18% · CORE · VALID
Evidence method
Level · gp.fundamentals.cash
$43.4M · CORE · VALID
Evidence method
Sequential · gp.financial.loans
9.45% · CORE · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History41 statesSelf-history eligible
Dec 31, 20215/6 normalizedLevel 3Mar 31, 20225/6 normalizedLevel 3Jun 30, 20225/6 normalizedLevel 3Sep 30, 20225/6 normalizedLevel 3Dec 31, 20226/6 normalizedLevel 3Dec 31, 20226/6 normalizedAmended as filedMar 31, 20236/6 normalizedLevel 3Jun 30, 20236/6 normalizedLevel 3Sep 30, 20236/6 normalizedLevel 3Dec 31, 20236/6 normalizedLevel 3Mar 31, 20246/6 normalizedLevel 3Jun 30, 20245/5 normalizedLevel 3Sep 30, 20244/4 normalizedLevel 3Dec 31, 20244/4 normalizedLevel 3Mar 31, 20254/4 normalizedLevel 3Jun 30, 20254/4 normalizedLevel 3Sep 30, 20254/4 normalizedLevel 3Dec 31, 20254/4 normalizedLevel 3Mar 31, 20264/4 normalizedLevel 3Jun 30, 20264/4 normalizedLevel 4
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.